Publications in collaboration with researchers from Instituto de Investigación Sanitaria Gregorio Marañón (10)

2023

  1. Antimicrobial Defined Daily Dose in Neonatal Population: Validation in the Clinical Practice

    Antibiotics, Vol. 12, Núm. 3

2022

  1. Multicenter randomized clinical trial comparing dexamethasone versus placebo in preventing upper airway obstruction after extubation in critically ill children

    Scientific Reports, Vol. 12, Núm. 1

2021

  1. COVID-19 in hospitalised patients in Spain: a cohort study in Madrid

    International Journal of Antimicrobial Agents, Vol. 57, Núm. 2

  2. Clinical course of severe patients with COVID-19 treated with tocilizumab: report from a cohort study in Spain

    Expert Review of Clinical Pharmacology, Vol. 14, Núm. 2, pp. 249-260

  3. Correction to: Standardization and Chemical Characterization of Intravenous Therapy in Adult Patients: A Step Further in Medication Safety (Drugs in R&D, (2021), 21, 1, (39-64), 10.1007/s40268-020-00329-w)

    Drugs in R and D

  4. Standardization and Chemical Characterization of Intravenous Therapy in Adult Patients: A Step Further in Medication Safety

    Drugs in R and D, Vol. 21, Núm. 1, pp. 39-64

2019

  1. Variability in management and outcomes of therapy with eculizumab in atypical hemolytic uremic syndrome

    Expert Opinion on Orphan Drugs, Vol. 7, Núm. 12, pp. 525-533

2018

  1. Estudio comparativo de contaminación de tres sistemas cerrados para la preparación de fármacos peligrosos mediante simulación con fluoresceína

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 42, Núm. 6, pp. 234-238

2017

  1. Improving pharmacotherapy outcomes in patients with hepatitis C virus infection treated with direct-acting antivirals: The GRUviC project

    International Journal of Clinical Practice, Vol. 71, Núm. 8

2016

  1. Effectiveness and Safety of Ombitasvir-Paritaprevir/Ritonavir and Dasabuvir With or Without Ribavirin for HCV Genotype 1 Infection for 12 Weeks Under Routine Clinical Practice

    Annals of Pharmacotherapy, Vol. 50, Núm. 11, pp. 901-908